Positive results showed the TSST-1 vaccine is effective with immunisation lasting for at least two years

The companies anticipate that the EMA could also recommend marketing authorisation for AVT04

The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients

The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere

Updated Date: Tue, 31 Jan 2023 00:00:00 EST

Financing will allow company’s development of DNA synthesis chip technology to commercial scale

Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure

Researchers have used single carbon atom doping to form four chemical bonds in one step. Gamma-lactams (cyclic molecules […]

Charity highlights the need to find kidney cancer early and for better guidance among doctors

Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar